Display options
Cite
Barlas S. The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?. P T. 2016;41(11):667
Barlas, S. (2016). The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?. P & T : a peer-reviewed journal for formulary management, 41(11), 667.
Barlas, Stephen. "The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?." P & T : a peer-reviewed journal for formulary management vol. 41,11 (2016): 667.
Barlas S. The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?. P T. 2016 Nov;41(11):667. PMID: 27904297; PMCID: PMC5083072.
Copy Download .nbib Format: NLM
Share it on

P T. 2016 Nov;41(11):667.

The Push for Additional Orphan Drugs: Can the FDA Do More to Encourage Their Development?.

P & T : a peer-reviewed journal for formulary management

Stephen Barlas

PMID: 27904297 PMCID: PMC5083072

Abstract

Can the FDA do more to encourage orphan drug development?

Publication Types